Anupamaa Seshadri

Anupamaa Seshadri

Auto-generated profile, based on publicly available information

Anupamaa Seshadri

Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Surgery
Verified
Journal Article
Closed access
JHJuan P. Herrera-Escobar
Juan P. Herrera-Escobar
SRSyeda S. Al Rafai
Syeda S. Al Rafai
ASAnupamaa J. Seshadri
Anupamaa J. Seshadri
CWChristina Weed
Christina Weed
MAMichel Apoj
Michel Apoj
DNDeepika Nehra
Deepika Nehra

12 May 2023 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
PDF file
ASAnupamaa Seshadri
Anupamaa Seshadri
JCJoseph Cuschieri
Joseph Cuschieri
KKKrista L Kaups
Krista L Kaups
LKLisa Marie Knowlton
Lisa Marie Knowlton
MKMatthew E Kutcher
Matthew E Kutcher
CMChristopher P Michetti
Christopher P Michetti
The Critical Care Committee of the American Association for the Surgery of Trauma (AAST) develops clinical consensus documents to provide practical guidance on challenging topics. The basis of these documents is expert consensus after a review of the recent literature to provide up-to-date best practices for the bedside clinician. The Critical Care Committee chose the care of the patient prior to organ donation in the intensive care unit (ICU) as a topic for review.

21 November 2022 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
PDF file
ASAnupamaa Seshadri
Anupamaa Seshadri
RARachel Appelbaum
Rachel Appelbaum
SCSamuel P Carmichael
Samuel P Carmichael
MFMichael Steven Farrell
Michael Steven Farrell
DFDina M Filiberto
Dina M Filiberto
CMChristopher P Michetti
Christopher P Michetti
Alcohol withdrawal syndrome is a common and challenging clinical entity present in trauma and surgical intensive care unit (ICU) patients. The screening tools, assessment strategies, and pharmacological methods for preventing alcohol withdrawal have significantly changed during the past 20 years. This Clinical Consensus Document created by the American Association for the Surgery of Trauma Critical Care Committee reviews the best practices for screening, monitoring, and prophylactic treatment of alcohol withdrawal in the surgical ICU.

23 January 2023 in Shock
Verified
Journal Article
Closed access
LHLara Hoteit
Lara Hoteit
PLPatricia Loughran
Patricia Loughran
SHShannon Haldeman
Shannon Haldeman
DRDanielle Reiser
Danielle Reiser
NANijmeh Alsaadi
Nijmeh Alsaadi
ASAnupamaa Seshadri
Anupamaa Seshadri
Introduction: Trauma alters the immune response in numerous ways, affecting both the innate and adaptive responses. Macrophages play an important role in inflammation and wound healing following injury. We hypothesize that macrophages mobilize from the circulation to the site of injury and secondary sites after trauma, with a transition from proinflammatory (M1) shortly after trauma to anti-inflammatory (M2) at later time points. Methods: C57Bl6 mice (n = 6/group) underwent a polytrauma model using cardiac puncture/hemorrhage, pseudofemoral fracture, and liver crush injury. The animals were killed at several time points: uninjured, 24 h, and 7 days. Peripheral blood mononuclear cells, spleen, liver nonparenchymal cells, and lung were harvested, processed, and stained for flow cytometry. Macrophages were identified as CD68+; M1 macrophages were identified as iNOS+; M2 macrophages as arginase 1+. Results: We saw a slight presence of M1 macrophages at baseline in peripheral blood mononuclear cells (6.6%), with no significant change at 24 h and 7 days after polytrauma. In contrast, the spleen has a larger population of M1 macrophages at baseline (27.7%), with levels decreasing at 24 h and 7 days after trauma (20.6% and 12.6%, respectively). A similar trend is seen in the lung where at baseline 14.9% of CD68+ macrophages are M1, with subsequent continual decrease reaching 8.7% at 24 h and 4.4% at 7 days after polytrauma. M1 macrophages in the liver represent 14.3% of CD68+ population in the liver nonparenchymal cells at baseline. This percentage increases to 20.8% after trauma and decreases at 7 days after polytrauma (13.4%). There are few M2 macrophages in circulating peripheral blood mononuclear cells and in spleen at baseline and after trauma. The percentage of M2 macrophages in the lungs remains constant after trauma (7.2% at 24 h and 9.2% at 7 days). In contrast, a large proportion of M2 macrophages are seen in the liver at baseline (36.0%). This percentage trends upward and reaches 45.6% acutely after trauma and drops to 21.4% at 7 days. The phenotypic changes in macrophages seen in the lungs did not correlate with a functional change in the ability of the macrophages to perform oxidative burst, with an increase from 2.0% at baseline to 22.1% at 7 days after polytrauma (P = 0.0258). Conclusion: Macrophage phenotypic changes after polytrauma are noted, especially with a decrease in the lung M1 phenotype and a short-term increase in the M2 phenotype in the liver. However, macrophage function as measured by oxidative burst increased over the time course of trauma, which may signify a change in subset polarization after injury not captured by the typical macrophage phenotypes.

1 August 2022 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
PDF file
ASAnupamaa Seshadri
Anupamaa Seshadri
RARachel Appelbaum
Rachel Appelbaum
SCSamuel P Carmichael
Samuel P Carmichael
JCJoseph Cuschieri
Joseph Cuschieri
JHJason Hoth
Jason Hoth
CMChristopher P Michetti
Christopher P Michetti
Management of decompensated cirrhosis (DC) can be challenging for the surgical intensivist. Management of DC is often complicated by ascites, coagulopathy, hepatic encephalopathy, gastrointestinal bleeding, hepatorenal syndrome, and difficulty assessing volume status. This Clinical Consensus Document created by the American Association for the Surgery of Trauma Critical Care Committee reviews practical clinical questions about the critical care management of patients with DC to facilitate best practices by the bedside provider.

9 June 2026 in Critical Care Medicine
Verified
Journal Article
Closed access
ASAnupamaa J. Seshadri
Anupamaa J. Seshadri
PAPaula Alves
Paula Alves
HKHyo In Kim
Hyo In Kim
ASAbhiram Singh
Abhiram Singh
JHJames Harbison
James Harbison
LOLeo E. Otterbein
Leo E. Otterbein
OBJECTIVE: Traumatic brain injury (TBI) leads to immune dysregulation, which predisposes patients to infections. We hypothesized that TBI leads to poor lung bacterial clearance, due at least in part to dysfunctional neutrophil (PMN) responses. In this study, we characterized both murine and porcine models of TBI plus lung bacterial inoculation to evaluate the effects of TBI on bacterial clearance, and tested the effects of plasma harvested from human TBI patients on PMN function. DESIGN: C57BL6 mice or Yucatan mini swine underwent sham (anesthesia only) or a mild TBI using standardized methods. Four hours later, mice were inoculated with Staphylococcus aureus . Pigs were inoculated with Actinobacter pleuropneumoniae immediately after TBI. At prespecified timepoints after inoculation (24 hr for mice and 72 hr for pigs), animals were euthanized and bronchoalveolar lavage (BAL) and blood were collected, and lung was harvested for further analyses. Plasma from TBI patients was used to perform in vitro assessment of PMN function. Subjects: C57BL6 mice, Yucatan mini swine, healthy volunteers, and TBI patients. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: In both animal models, TBI predisposed to poor pulmonary bacterial clearance despite significantly increased PMNs in BAL and blood. In vitro, treatment of PMNs with plasma or plasma-derived extracellular vesicles (EVs) from TBI patients led to increased nondirectional chemokinesis, less reactive oxygen species production, and decreased ability to phagocytose. CONCLUSIONS: TBI leads to decreased bacterial clearance in the lung in models of TBI + bacterial lung infection, despite increased PMN counts in lung and blood. This is secondary to inappropriate PMN function after TBI, which we demonstrated in vitro via multiple functional assays to be caused, in part, by systemic factors in the plasma, including EVs. Further studies are required to understand the link between TBI and PMN dysfunction that leads to increased susceptibility to bacterial lung infection.